BATM says associate company to develop STI tests with French research institute
Through its collaboration with BIOASTER, a French microbiology technology research institute, BATM said it expects to speed up the development of an STI panel
Company
LON:BVC
BATM Advanced Communications Ltd is a leading provider of real-time technologies for networking and cyber security solutions and for bio-medical and bio-waste treatment solutions via its two operating divisions. The company's disruptive, transformative technology is backed by strong intellectual property and patents, which is the foundation for the development of its market-leading, innovative and cost-effective solutions.
261 stories · page 2 of 14
Through its collaboration with BIOASTER, a French microbiology technology research institute, BATM said it expects to speed up the development of an STI panel
Hardware & electrical equipment
The 'house' broker's analysts said: "We believe that this partnership model, commercialising Edgility, is ultimately set to be repeated with other potential network providers in the UK and worldwide"
Hardware & electrical equipment
CityFibre recently raised £4.9bn to finance its full-fibre roll-out to connect 8mln homes, 1.2mln business and public sector premises
Shore Capital believes the cyber security solutions company presents a "profitable high-growth opportunity to investors across a span of technologies"
Marom is stepping down as CEO on 1 January 2023, but will remain a non-executive director of BATM
CEO Dr Zvi Marom said the group had entered the second half with "sustained momentum and a significant backlog to be delivered against"
During the pandemic he oversaw the development of the BriLife COVID-19 vaccine at IIBR
Hardware & electrical equipment
“The selection of Edgility by such a significant telecoms company is a fantastic validation"
Dr Avigdor Shafferman was previously an external director of the company
Edgility will be pre-installed on NEXCOM's 5G network appliance
Results in 2021 revealed a sharp increase in underlying earnings from continuing operations
BATM's software will be embedded in Advantech's products
However, the FTSE Russell index reclassification will go ahead and the company's shares will no longer be eligible for inclusion in UK indices from 21 March
BATM’s nationality will be reassigned by FTSE Russell to Israel on 21 March at which point it will cease to be eligible for inclusion in the index compiler's UK indices
"This investment will enable us to prepare Ador for the pre-production stage and move it towards becoming a commercial clinical solution," said BATM CEO Dr Zvi Marom
The RAPiDgen test solution is a strong example of BATM’s product capabilities
The company has commenced shipping its first order, worth €250,000, and expects further orders of a greater value next year
A glance at some of the day's highlights from the Proactive Investors newswire
The latest mutation of the COVID virus has caused widespread concern
It is the latest is in a series of deals with government customers in recent months